These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18524592)

  • 1. Effect of some P-glycoprotein modulators on Rhodamine-123 absorption in guinea-pig ileum.
    Colabufo NA; Berardi F; Contino M; Inglese C; Niso M; Perrone R
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3741-4. PubMed ID: 18524592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
    Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
    Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF
    Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of intestinal P-glycoprotein activity by 2n-propylquinoline, a new oral treatment for visceral leishmaniasis.
    Belliard AM; Leroy C; Banide H; Farinotti R; Lacour B
    Exp Parasitol; 2003; 103(1-2):51-6. PubMed ID: 12810046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.
    Nüssler V; Pelka-Fleisc R; Gieseler F; Hasmann M; Löser R; Gullis E; Stötzer O; Zwierzina H; Wilmanns W
    Leuk Lymphoma; 1998 Nov; 31(5-6):589-97. PubMed ID: 9922050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
    Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional difference in P-glycoprotein function in rat intestine.
    Iida A; Tomita M; Hayashi M
    Drug Metab Pharmacokinet; 2005 Apr; 20(2):100-6. PubMed ID: 15855720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T
    Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism.
    Guan Y; Huang J; Zuo L; Xu J; Si L; Qiu J; Li G
    Arch Pharm Res; 2011 Oct; 34(10):1719-28. PubMed ID: 22076772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of intestinal absorption of P-glycoprotein substrate by D-tartaric acid.
    Iida A; Tomita M; Idota Y; Takizawa Y; Hayashi M
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):424-8. PubMed ID: 17072096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of P-glycoprotein in berberine absorption.
    Pan GY; Wang GJ; Liu XD; Fawcett JP; Xie YY
    Pharmacol Toxicol; 2002 Oct; 91(4):193-7. PubMed ID: 12530470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion.
    Veau C; Leroy C; Banide H; Auchère D; Tardivel S; Farinotti R; Lacour B
    Nephrol Dial Transplant; 2001 Aug; 16(8):1607-14. PubMed ID: 11477162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
    Pajeva IK; Wiese M
    J Med Chem; 2002 Dec; 45(26):5671-86. PubMed ID: 12477351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
    Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
    Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
    Werle M; Hoffer M
    J Control Release; 2006 Mar; 111(1-2):41-6. PubMed ID: 16377016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A.
    Bekaii-Saab TS; Perloff MD; Weemhoff JL; Greenblatt DJ; von Moltke LL
    Biopharm Drug Dispos; 2004 Oct; 25(7):283-9. PubMed ID: 15386482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo.
    Li H; Yan Z; Ning W; Xiao-Juan G; Cai-Hong Z; Jin-Hua J; Fang M; Qing-Duan W
    J Biomed Biotechnol; 2011; 2011():281651. PubMed ID: 21765632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers.
    Zastre J; Jackson J; Bajwa M; Liggins R; Iqbal F; Burt H
    Eur J Pharm Biopharm; 2002 Nov; 54(3):299-309. PubMed ID: 12445560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450.
    Zhu S; Huang R; Hong M; Jiang Y; Hu Z; Liu C; Pei Y
    Eur J Pharm Sci; 2009 Jul; 37(5):573-80. PubMed ID: 19442720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.